• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Lipigon Pharmaceuticals AB

Headquarters: Umea, Sweden
Year Founded: 2010
Status: Public
Industry Sector: HealthTechnology
CEO: Johan Liwing
Number Of Employees: N/A
Enterprise Value: N/A
PE Ratio: -0.73
Exchange/Ticker 1: SSE:LPGO
Exchange/Ticker 2: N/A
Latest Market Cap: $5,832,418

BioCentury | Nov 1, 2018
Emerging Company Profile

Secarna’s next-gen oligos

Why Secarna is developing antisense oligonucleotides for immuno-oncology
BioCentury | Dec 3, 2012
Emerging Company Profile

Lipigon: LPL protectorate

Lipigon taking new approach to lipoprotein lipase to prevent atherosclerosis
Items per page:
1 - 2 of 2
Help Center
Username
Request Training
Submit Data Correction
Ask a Question